Business Context and Reporting Period
This Form 8-K is filed by Zafgen, Inc. (not Larimar Therapeutics, Inc.) on August 13, 2014. The report announces the financial results for the quarter ended June 30, 2014. The filing serves to furnish a press release (Exhibit 99.1) containing the detailed results.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the announcement of the Q2 2014 results.
Guidance, Outlook, and Risks
The text does not include management commentary, guidance, outlook, or specific risk factors. It explicitly states that the information in this report and Exhibit 99.1 is "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name is Zafgen, Inc., as the input metadata incorrectly listed Larimar Therapeutics, Inc.
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are absent from the 8-K body text.
- Confirm the reporting period is the quarter ended June 30, 2014.
- Note that the furnished information is not legally "filed" under Section 18 of the Exchange Act.